Postoperative intravenous parecoxib sodium followed by oral celecoxib post total knee arthroplasty in osteoarthritis patients (PIPFORCE): a multicentre, double-blind, randomised, placebo-controlled trial.
Qianyu ZhuangLiyuan TaoJin LinJin JinWenwei QianYanyan BianYulong LiYulei DongHuiming PengYe LiYu FanWei WangBin FengNa GaoTiezheng SunJianhao LinMiaofeng ZhangShigui YanBin ShenFuxing PeiXisheng WengPublished in: BMJ open (2020)
ClinicalTrials.gov (ID: NCT02198924).
Keyphrases
- double blind
- clinical trial
- total knee arthroplasty
- placebo controlled
- study protocol
- end stage renal disease
- ejection fraction
- newly diagnosed
- chronic kidney disease
- patients undergoing
- rheumatoid arthritis
- open label
- randomized controlled trial
- phase iii
- prognostic factors
- phase ii
- high dose
- total hip
- cross sectional
- low dose